Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off
Comparison of Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Without Moses 2.0 Pulse Modulation
Northwestern University
150 participants
Jun 9, 2023
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology. The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Eligibility
Inclusion Criteria3
- Undergoing ureteroscopy and laser lithotripsy
- Stone size ≥8 but \< 20 mm in the proximal ureter or kidney. Multiple stones ≤4 are allowed. Bilateral surgeries are allowed
- Willing to sign informed consent
Exclusion Criteria5
- Staged surgery
- Nephrocalcinosis
- Participant is less than 18 years of age
- Inability to provide informed consent
- Members of vulnerable patient populations
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Lumenis Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology used for lithotripsy and BPH treatments
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06346483